Perfluorocarbons: Future Clinical Possibilities

References

• Clark L C, Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152: 1755–1756
   PubMed Web of Science ®Google Scholar
• Clark L C, Jr. Introduction to fluorocarbons. Int Anesth CI. 1985; 23: 1–9
   PubMedGoogle Scholar
• Biro G P. Perfluorocarbon-based red blood cell substitutes. Transfus Med Rev. 1993; 7: 84–95
   PubMedGoogle Scholar
• Ohyanagi H, Saitoh Y. Development and clinical application of perfluorochemical artificial blood. Int I Artif Organs 1986; 9: 363–368
   PubMed Web of Science ®Google Scholar
• Marelli T R. Use of a hemoglobin substitute in the anemic Jehovah's witness patient. Crit Care Nurse. 1994; 14(2)31–38
   PubMedGoogle Scholar
• Shah N, Mehra A. Modeling of oxygen uptake in perfluorocarbon emulsions. ASAIO J. 1996; 42: 181–189
   PubMedGoogle Scholar
• Mitsuno T, Ohyanagi H, Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann Surg. 1982; 195: 60–69
   PubMed Web of Science ®Google Scholar
• Lowe K C. Perfluorocarbons as oxygen transport fluids. Comp Biochem Physiol 1987; 87A(4)825–838
   Google Scholar
• Tremper K K, Friedman A E, Levine E M, Lapin R, Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med. 1982; 307: 277–283
   PubMed Web of Science ®Google Scholar
• Tremper K K, Vercellotti G M, Hammerschmidt D E. Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20%. Crit Care Med. 1984; 12: 428–431
   PubMedGoogle Scholar
• Waxman K, Tremper K K, Cullen B F, Mason G R. Perfluorocarbon infusion in bleeding patients refusing blood transfusions. Arch Surg. 1984; 119: 721–724
   PubMed Web of Science ®Google Scholar
• Police A M, Waxman K, Tominaga G. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit Care Med. 1985; 13: 96–98
   PubMed Web of Science ®Google Scholar
• Kale P B, Sklar G E, Wesolowicz L A, DiLisio R E. Fluosol: Therapeutic failure in severe anemia. Ann Pharmacother 1993; 27: 1452–1454
   PubMedGoogle Scholar
• Ingram D A, Forman M B, Murray J J. Activation of complement by Fluosol attributable to the pluronic detergent micelle structure. J Cardiovasc Pharmacol. 1993; 22: 456–461
   PubMed Web of Science ®Google Scholar
• Vercellotti G M, Hammerschmidt D E, Craddock P R, Jacob H S. Activation of plasma complement by perfluorocarbon artificial blood: Probable mechanism of adverse pulmonary reactions in treated patients and rationale for cortico-steroid prophylaxis. Blood 1982; 59: 1299–1304
   PubMed Web of Science ®Google Scholar
• Bollands A D, Lowe K C. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence. Comp Biochem Physiol 1986; 85C: 309–312
   Google Scholar
• Lowe K C, Washington C. Emulsified perfluorochemicals as respiratory gas carriers: Recovery of perfluorodecalin emulsion droplets from rat tissues. J Pharm Pharmacol. 1993; 45: 938–941
   PubMedGoogle Scholar
• Bentley P K, Johnson O L, Washington C, Lowe K C. Uptake of concentrated perfluorocarbon emulsions into rat lymphoid tissues. J Pharm Pharmacol. 1993; 45: 182–185
   PubMedGoogle Scholar
• Lau P, Shankar V S, Mayer L L, Wurzel H A, Sloviter. Coagulation defects in rabbits after infusion of dispersed fluoro-chemicals. Transfusion 1975; 15: 432–438
   PubMedGoogle Scholar
• Smith D J, Lane T A. Effect of a high concentration perflubron emulsion on platelet function. Biomat Art Cells Immob Biotech. 1993; 21: 173–181
   PubMed Web of Science ®Google Scholar
• Castro O, Nesbitt A E, Lyles D. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Am J Hematol. 1984; 16: 15–21
   PubMed Web of Science ®Google Scholar
• Castro O, Reindorf C A, Socha W W, Rowe A W. Perfluorocarbon enhancement of heterologous red cell survival: A reticuloendothelial block effect?. Int Arch Allergy Appl Immunol 1983; 70: 88–91
   PubMedGoogle Scholar
• Virmani R, Warren D, Rees R, Fink L M, English D. Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 1983; 223: 512–515
   Google Scholar
• Lane T A, Lamkin G E. Paralysis of phagocyte migration due to an artificial blood substitute. Blood 1984; 64: 400–405
   PubMedGoogle Scholar
• Bucala R, Kawakami M, Cerami A. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro. Science 1983; 220: 965–967
   PubMed Web of Science ®Google Scholar
• Kylstra J A, Tissing M O, van der Maen A. Of mice as fish. Trans Am Soc Artif Int Organs 1962; 8: 378–383
   PubMedGoogle Scholar
• Schwieler G H, Robertson B. Liquid ventilation in immature newborn rabbits. Biol Neonate. 1976; 29: 343–353
   PubMedGoogle Scholar
• Bhutani V K, Shaffer T H. Effect of liquid ventilation of preterm lamb tracheal mechanics. Biol Neonate. 1983; 44: 257–263
   PubMedGoogle Scholar
• Greenspan J S, Wolfson M R, Rubenstein S D, Shaffer T H. Liquid ventilation of human preterm neonates. J Pediatr 1990; 117: 106–111
   PubMed Web of Science ®Google Scholar
• Lowe C, Tuma R F, Sivieri E M, Shaffer T H. Liquid ventilation: Cardiovascular adjustments with secondary hyperlactatemia and acidosis. J Appl Physiol. 1979; 47: 1051–1057
   PubMedGoogle Scholar
• Curtis S E, Fuhrman B P, Howland D F, De Francisis M, Motoyama E K. Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets. Crit Care Med. 1991; 19: 225–230
   PubMed Web of Science ®Google Scholar
• Degraeuwe P L, Vos G D, Blanco C E. Perfluorochemical liquid ventilation: From the animal laboratory to the intensive care unit. Int J Artif Organs 1995; 18(10)674–683
   PubMedGoogle Scholar
• Varani J, Hirschl R B, Dame M, Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock. 1996; 6(5)339–344
   PubMedGoogle Scholar
• Martin S M, Laks H, Drinkwater D C, Stein D G, Capouya E R, Pearl J M, Barthel S W, Chang P, Kaczer E, Bhuta S. Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia. Ann Thorac Surg. 1993; 55: 954–960
   PubMedGoogle Scholar
• Honda K, Motoki R, Hoshino S, Inoue H, UsubaHamada O, Iwaya F, Ando M. Use of perfluorochemical artificial blood (Fluosol-DA) for perfusion of cadaveric kidneys for transplantation. Curr Ther Res. 1980; 28: 309–318
   Google Scholar
• Kamada N, Calne R Y, Wight D GD, Lines J G. Orthotopic rat liver transplantation after long-term preservation by continuous perfusion with fluorocarbon emulsion. Transplantation 1980; 30: 43–48
   PubMed Web of Science ®Google Scholar
• Glogar D H, Kloner R A, Muller J, De Boer L WV, Braunwald E. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 1981; 211: 1439–1441
   PubMed Web of Science ®Google Scholar
• Forman M B, Bingham S, Kopelman H A, Wehr C, Sandler M P, Kolodgie F, Vaughn W K, Friesinger G C, Virmani R. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1985; 71: 1060–1068
   PubMed Web of Science ®Google Scholar
• Wall T C, Califf R M, Blankenship J, Talley J D, Tannenbaum M, Schwaiger M, Gacioch G, Cohen M D, Sanz M, Leimberger J D, Topol E J. Intravenous fluosol in the treatment of acute myocardial infarction. Circulation 1994; 90: 114–120
   PubMed Web of Science ®Google Scholar
• Sutherland G R, Farrar J K, Peerless S J. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia. Stroke 1984; 15: 829–835
   PubMed Web of Science ®Google Scholar
• Peerless S J, Nakamura R, Rodriguez-Salazar A, Hunter I G. Modification of cerebral ischemia with fluosol. Stroke 1985; 16: 38–43
   PubMedGoogle Scholar
• Peerless S J, Ishikawa R, Hunter I G, Peerless M J. Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke 1981; 12: 558–563
   PubMed Web of Science ®Google Scholar
• Suzuki J, Fujimoto S, Mizoi K, Oba M. The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 1984; 15: 672–679
   PubMed Web of Science ®Google Scholar
• Kent K M, Clemen M W, Cowley M J, Forman M B, Jaffe C C, Kaplan M, King S B, III, Krucoff M W, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated fluosol. Am J Cardiol. 1990; 66: 279–284
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie F D, Osmialowski A, Zimmerman P, Mergner W, Forman M B. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion. Am Heart J. 1988; 116: 421–431
   PubMed Web of Science ®Google Scholar
• Jaffe C C, Wohlgelernter D, Cabin H, Bowman L, Deckelbaum L, Remetz M, Cleman M. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%. Am Heart J. 1988; 115: 1156–1164
   PubMed Web of Science ®Google Scholar
• Klein J, Faithfull N S, Salt P J, Trouwborst A. Transperitoneal oxygenation with fluorocarbons. Anesth Analg. 1986; 65: 734–738
   PubMed Web of Science ®Google Scholar
• Schmidt J A, Bilge F H, Colacino J M, von Recum A F. Peritoneal oxygenation of normoxic and hypoxic dogs. ASAIO Trans. 1989; 35: 35–39
   PubMedGoogle Scholar
• Lutz J, Hermann G. Perfluorochemicals as a treatment of decompression sickness in rats. Pflügers Arch. 1984; 401: 174–177
   PubMed Web of Science ®Google Scholar
• Kuwamura K, Kokunai T, Tamaki N, Matsumoto S. Synergistic effect of perfluorochemicals on BCNU chemotherapy. J Neurosurg. 1982; 57: 467–471
   PubMed Web of Science ®Google Scholar
• Klubes P, Hiraga S, Cysyk R L, Owens E S, Blasberg R G. Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of the perfluorocarbon emulsion Fluosol-DA. fur J Cancer Clin Oncol. 1987; 23: 1859–1867
   PubMedGoogle Scholar